This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Friedman, J.M. Search for Related Content PubMed PubMed Citation Articles by Friedman, J.M. Social Bookmarking                         What's this?

Review Article : Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria

Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada

Neurofibromatosis 1 occurs in 2 to 3 people per 10,000. The most frequent clinical features are café-au-Iait macules, neurofibromas, intertriginous freckling, Lisch nodules, and learning disabilities, but optic and other gliomas, malignant peripheral nerve sheath tumors, and characteristic osseous lesions also can be present. Two striking aspects of neurofibromatosis 1 are its progressive nature and its extreme variability. This article reviews the natural history and some important clinical manifestations of neurofibromatosis 1, with emphasis on features that constitute the standard diagnostic criteria. The pathogenic implications of these clinical manifestations are also considered. (J Child Neurol 2002;17:548-554).

Journal of Child Neurology, Vol. 17, No. 8, 548-554 (2002)
DOI: 10.1177/088307380201700802


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. G. Slomiany, L. Dai, P. A. Bomar, T. J. Knackstedt, D. A. Kranc, L. Tolliver, B. L. Maria, and B. P. Toole Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides Cancer Res., June 15, 2009; 69(12): 4992 - 4998. [Abstract] [Full Text] [PDF]

				V. C. Williams, J. Lucas, M. A. Babcock, D. H. Gutmann, B. Korf, and B. L. Maria Neurofibromatosis Type 1 Revisited Pediatrics, January 1, 2009; 123(1): 124 - 133. [Abstract] [Full Text] [PDF]

				L. Margari, A. Presicci, P. Ventura, S. M. Bacca, G. Iliceto, N. Medicamento, M. Buttiglione, and T. Perniola Clinical and Instrumental (Magnetic Resonance Imaging [MRI] and Multimodal Evoked Potentials) Follow-Up of Brain Lesions in Three Young Patients With Neurofibromatosis 1 J Child Neurol, December 1, 2006; 21(12): 1085 - 1090. [Abstract] [PDF]

				K. P. Pummi, H. J. Aho, M. K. Laato, J. T.K. Peltonen, and S. A. Peltonen Tight Junction Proteins and Perineurial Cells in Neurofibromas J. Histochem. Cytochem., January 1, 2006; 54(1): 53 - 61. [Abstract] [Full Text] [PDF]

				S. A. M. Thomson, L. Fishbein, and M. R. Wallace Review Article : NF1 Mutations and Molecular Testing J Child Neurol, August 1, 2002; 17(8): 555 - 561. [Abstract] [PDF]

				D. Viskochil Review Article : Genetics of Neurofibromatosis 1 and the NF1 Gene J Child Neurol, August 1, 2002; 17(8): 562 - 570. [Abstract] [PDF]